- FDA acting chief walks back Makary's practice of policymaking through journalsThe FDA is continuing to rewind actions by former Commissioner Marty Makary, saying that two medical journal articles published over the last year did not constitute agency policy. The about-face f…Endpoints · 13d ago↗ source
- Senate committee questions CDC pick on political interference over vaccinesLawmakers in the Senate pressed the Trump administration’s nominee for CDC director on whether she will cave to political pressure during a confirmation hearing on Wednesday. The CDC has been witho…Endpoints · 13d ago↗ source
- Amid $55B US manufacturing push, J&J turns to streamlining its pharma supply chainAfter committing $55 billion last year to bolster U.S. manufacturing capabilities, Johnson & Johnson is making changes to its pharmaceutical supply chain.